Previous reviews have compared various uterotonics (including oxytocin) versus placebo or other agents in different doses, regimens and timing of administration for preventing PPH at CS.14 43 However, to the best of our knowledge, this is the first systematic review to assess different routes of oxytocin administration for preventing PPH in women giving birth by CS. The gene discussed is OXT; the disease is pulmonary arterial hypertension.